This meeting is designed as a unique context aimed at sharing ideas and data on MRI contrast agents research and possible gadolinium toxicity after the administration of gadolinium-based contrast agents (GBCAs). We believe that joint international efforts will remain essential to optimize diagnostic efficacy and improve patient safety in MR imaging. Since 2016, the ESMRMB-GREC has adapted the contents of the discussion to current hot topics and has evolved in style even in difficult circumstances imposed by the pandemic restrictions.

Check back for details on the 8th GREC meeting soon!